Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Criteo S.A.CRTO · Entity 291 | Director · Chief Executive Officer | February 14, 2025 | February 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Criteo S.A.
Report date February 14, 2025 · Filed February 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 473,539 |
Last balance in matching sequence
After 2025-02-14 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2025-02-14 · Sale · Disposed 5,259 · Balance 482,970 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F2: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $43.92 to $44.22 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Row 2 · 2025-02-14 · Sale · Disposed 5,332 · Balance 477,638 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F4: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $43.65 to $43.81 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Row 3 · 2025-02-14 · Sale · Disposed 4,099 · Balance 473,539 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share. F5: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $43.33 to $43.48 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.
F2: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $43.92 to $44.22 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3: For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
F4: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $43.65 to $43.81 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $43.33 to $43.48 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2019 Filed Dec 13, 2019 21:04 UTC | Criteo S.A. CRTO · Entity 291 | GrantStock Option (right to buy) · Derivative | 375,467 | $0.00 Strike: $17.35 | $0.00 |
DisclosureSEC source: 0001576427-19-000113 · wf-form4_157627103381065.xml · derivative · entry 2 Clarken Megan · CIK 0001795120 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,467 Underlying: Ordinary Shares · 375,467 shares Expires 2029-12-11 F3 · derivative.exercise_price: The exercise price of the stock option is 15.67 euros. The U.S. dollar equivalent of the exercise price is $17.35 using the European Central Bank rate as of December 11, 2019 (1.00 = $1.1075). F4 · derivative.exercise_date: Stock options granted on December 11, 2019. One-fourth of the grant vests on the first anniversary of the grant date and additional 1/16th of the grant vests quarterly thereafter for a period of 36 months, subject to continued service through each vesting date. F1 · derivative.underlying: The Ordinary Shares may be represented by American Depository Shares, each of which currently represents one Ordinary Share. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:04 UTC | Criteo S.A. CRTO · Entity 291 | GrantOrdinary Shares | 143,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001576427-19-000113 · wf-form4_157627103381065.xml · nonDerivative · entry 1 Clarken Megan · CIK 0001795120 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,308 F1 · security: The Ordinary Shares may be represented by American Depository Shares, each of which currently represents one Ordinary Share. F2 · shares: The shares are subject to time based vesting as follows: 50% of the shares will vest on the two-year anniversary of the grant date, and the remainder will vest in equal portions at the end of each quarter during the two-year period thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.